These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2422737)

  • 1. HLA class-II-restricted Mycobacterium leprae-reactive T-cell clones from leprosy patients established with a minimal requirement for autologous mononuclear cells.
    Haanen JB; Ottenhoff TH; Voordouw A; Elferink BG; Klatser PR; Spits H; De Vries RR
    Scand J Immunol; 1986 Jan; 23(1):101-8. PubMed ID: 2422737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular localization and polymorphism of HLA class II restriction determinants defined by Mycobacterium leprae-reactive helper T cell clones from leprosy patients.
    Ottenhoff TH; Neuteboom S; Elferink DG; de Vries RR
    J Exp Med; 1986 Dec; 164(6):1923-39. PubMed ID: 2431092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mycobacterium leprae-specific protein antigens defined by cloned human helper T cells.
    Ottenhoff TH; Klatser PR; Ivanyi J; Elferink DG; de Wit MY; de Vries RR
    Nature; 1986 Jan 2-8; 319(6048):66-8. PubMed ID: 2417123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cloned suppressor T cells from a lepromatous leprosy patient suppress Mycobacterium leprae reactive helper T cells.
    Ottenhoff TH; Elferink DG; Klatser PR; de Vries RR
    Nature; 1986 Jul 31-Aug 6; 322(6078):462-4. PubMed ID: 2426597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetically restricted suppressor T-cell clones derived from lepromatous leprosy lesions.
    Modlin RL; Kato H; Mehra V; Nelson EE; Fan XD; Rea TH; Pattengale PK; Bloom BR
    Nature; 1986 Jul 31-Aug 6; 322(6078):459-61. PubMed ID: 2942780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA class II restricted helper and suppressor clones reactive with Mycobacterium leprae.
    de Vries RR; Ottenhoff TH; Li SG; Young RA
    Lepr Rev; 1986 Dec; 57 Suppl 2():113-21. PubMed ID: 2952853
    [No Abstract]   [Full Text] [Related]  

  • 7. Definition of a human suppressor T-cell epitope.
    Mutis T; Cornelisse YE; Datema G; van den Elsen PJ; Ottenhoff TH; de Vries RR
    Proc Natl Acad Sci U S A; 1994 Sep; 91(20):9456-60. PubMed ID: 7524076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of cytokine production by Mycobacterium-reactive T cells. Failure to explain Mycobacterium leprae-specific nonresponsiveness of peripheral blood T cells from lepromatous leprosy patients.
    Mutis T; Kraakman EM; Cornelisse YE; Haanen JB; Spits H; De Vries RR; Ottenhoff TH
    J Immunol; 1993 May; 150(10):4641-51. PubMed ID: 8482851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA class II+ human keratinocytes present Mycobacterium leprae antigens to CD4+ Th1-like cells.
    Mutis T; De Bueger M; Bakker A; Ottenhoff TH
    Scand J Immunol; 1993 Jan; 37(1):43-51. PubMed ID: 8418472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. M. leprae and PPD-triggered T cell lines in tuberculoid and lepromatous leprosy.
    Shankar P; Agis F; Wallach D; Flageul B; Cottenot F; Augier J; Bach MA
    J Immunol; 1986 Jun; 136(11):4255-63. PubMed ID: 2422278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T cell responses to fractionated Mycobacterium leprae antigens in leprosy. The lepromatous nonresponder defect can be overcome in vitro by stimulation with fractionated M. leprae components.
    Ottenhoff TH; Converse PJ; Gebre N; Wondimu A; Ehrenberg JP; Kiessling R
    Eur J Immunol; 1989 Apr; 19(4):707-13. PubMed ID: 2659369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr virus-transformed B cell lines present M. leprae antigens to T cells.
    Elferink BG; Ottenhoff TH; de Vries RR
    Scand J Immunol; 1985 Nov; 22(5):585-9. PubMed ID: 3001928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Mycobacterium leprae-specific human T cell epitope cross-reactive with an HLA-DR2 peptide.
    Anderson DC; van Schooten WC; Barry ME; Janson AA; Buchanan TM; de Vries RR
    Science; 1988 Oct; 242(4876):259-61. PubMed ID: 2459778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human T-cell clones with reactivity to Mycobacterium leprae as tools for the characterization of potential vaccines against leprosy.
    Emmrich F; Kaufmann SH
    Infect Immun; 1986 Mar; 51(3):879-83. PubMed ID: 3081446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypic and functional characterization of human suppressor T-cell clones: II. Activation by Mycobacterium leprae presented by HLA-DR molecules to alpha beta T-cell receptors.
    Li SG; Elferink DG; de Vries RR
    Hum Immunol; 1990 May; 28(1):11-26. PubMed ID: 1692823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T cell epitopes on the 36K and 65K Mycobacterium leprae antigens defined by human T cell clones.
    Van Schooten WC; Ottenhoff TH; Klatser PR; Thole J; De Vries RR; Kolk AH
    Eur J Immunol; 1988 Jun; 18(6):849-54. PubMed ID: 2454825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A systematic molecular analysis of the T cell-stimulating antigens from Mycobacterium leprae with T cell clones of leprosy patients. Identification of a novel M. leprae HSP 70 fragment by M. leprae-specific T cells.
    Janson AA; Klatser PR; van der Zee R; Cornelisse YE; de Vries RR; Thole JE; Ottenhoff TH
    J Immunol; 1991 Nov; 147(10):3530-7. PubMed ID: 1940353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mycobacterium leprae-reactive T-cell clones isolated from polar lepromatous and tuberculoid leprosy patients.
    Launois P; Shankar P; Wallach D; Flageul B; Cottenot F; Bach MA
    Ann Inst Pasteur Immunol; 1987; 138(5):723-35. PubMed ID: 2830893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low T lymphocyte responsiveness to Mycobacterium leprae antigens in association with HLA-DR3.
    van Eden W; Elferink BG; de Vries RR; Leiker DL; van Rood JJ
    Clin Exp Immunol; 1984 Jan; 55(1):140-8. PubMed ID: 6362932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycobacterium leprae-specific, HLA class II-restricted killing of human Schwann cells by CD4+ Th1 cells: a novel immunopathogenic mechanism of nerve damage in leprosy.
    Spierings E; de Boer T; Wieles B; Adams LB; Marani E; Ottenhoff TH
    J Immunol; 2001 May; 166(10):5883-8. PubMed ID: 11342602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.